Aparna Wagle Shukla, MD
Neurology · Springfield, ILNPI 1124228747
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $13,390 of the $13,792 with a category attached, or 97.1%. Biogen accounts for 62.6% of it on its own, with 6 other manufacturers making up the rest. 2024 is the largest year on record at $5,696, more than ten times the $132 reported in 2019.
Across 11 payments — averaging $1253.84 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Biogen$9K
- MDD US Operations, LLC$5K
- Eisai Inc.$125
- AbbVie$76
- Neurocrine Biosciences, Inc.$74
- Amneal Pharmaceuticals LLC$71
- plus $56 from 1 others
Across 9 payments — averaging $6942.06 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Sage Therapeutics, LLC$62K
What the payments were for
- Consulting fees$13,39097%
- Food & beverage$3262%
- Education$761%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Biogen | 3 | $8,630 |
| MDD US Operations, LLC | 2 | $4,760 |
| Eisai Inc. | 1 | $125 |
| AbbVie | 2 | $76 |
| Neurocrine Biosciences, Inc. | 1 | $74 |
| Amneal Pharmaceuticals LLC | 1 | $71 |
| Abbott | 1 | $56 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$13,792 in reported general payments places this provider in the 85th percentile of 790 neurology providers in Illinois.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Carbidopa-LevodopaCarbidopa/Levodopa | 93 | $3,004 |
| Baclofen | 31 | $491 |
| Clonazepam | 80 | $441 |
| Gabapentin | 29 | $351 |
| Propranolol Hcl | 22 | $245 |
| Carbidopa-Levodopa ErCarbidopa/Levodopa | 11 | $159 |
| Sertraline Hcl | 17 | $42 |
Paid to pharmacies, not to this prescriber.
Other neurology in Springfield
- Rodger ElbleSpringfield$47K
- Augusto MiravalleChicago$1.4M
- Lori GuytonHerrin$1.1M
- Daniel WynnNorthbrook$812K
- Arthur ItkinPalos Heights$808K
- Andrew GordonLake Barrington$765K
- Martha McGrawWinfield$625K
- Reuben ValenzuelaPeoria$590K
- Adil JavedChicago$584K
- Tyler KaplanMaywood$549K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.